Class Action

Rite Aid Acetaminophen Rapid Release Gelcaps

Class Action

Rite Aid Acetaminophen Rapid Release Gelcaps

September 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward.

November 2018: A class-action lawsuit was filed against Rite Aid for allegedly misleadingly marketing its Acetaminophen Rapid Release Gelcaps as being comparable to Tylenol® Extra Strength Rapid Release Gels when, according to plaintiffs, the Tylenol® Gels have “unique laser drilled holes” that the Rite Aid Gelcaps do not have. In addition, the complaint alleges that the Rite Aid gels are “rapid release” when, according to plaintiffs, the medicine does not work faster than non-rapid release products. (Bailey et al v. Rite Aid Corp., Case No. 18-cv-6926, N.D. Cal.)


Class-Action Tracker

Dreamhouse Fine Foods Gourmet Praline Pecans

Class Action

Dreamhouse Fine Foods Gourmet Praline Pecans

In October 2019, a class-action lawsuit was filed against Rite Aid for allegedly misleadingly representing that Dreamhouse Fine Foods Gourmet Praline Pecans contain “evaporated cane juice” when, according to plaintiffs,…

Kidcents Donations at Rite Aid

Class Action

Kidcents Donations at Rite Aid

In March 2019, a class-action lawsuit was filed against Rite Aid for allegedly misleading promoting the Kidcents donation program, a system for donating to charity by allowing Rite Aid to…

Rite Aid’s Nutritional Supplements

Class Action

Rite Aid’s Nutritional Supplements

November 2018: This lawsuit was transferred to a Pennsylvania court. (Case No. 18-cv-2135, M. D. PA.) February 2018: A class-action lawsuit was filed against Rite Aid for allegedly misleadingly stating…

Rite Aid Renewal After Sun Gel

Class Action

Rite Aid Renewal After Sun Gel

In September 2017, a class-action lawsuit was filed against Rite Aid for allegedly falsely advertising that its Renewal After Sun Gel is made of aloe when, according to the complaint,…


The Latest

Filters

Rite Aid

Ad Alert

Rite Aid

Drugstore chain’s No. 1 doctor-recommended claims come down in wake of NAD inquiry.